GlaxoSmithKline PLC (NYSE:GSK)

46.59
Delayed Data
As of Apr 24
 +0.28 / +0.60%
Today’s Change
41.25
Today|||52-Week Range
56.48
+9.01%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for GlaxoSmithKline have a median target of 46.25, with a high estimate of 54.83 and a low estimate of 38.10. The median estimate represents a -0.73% decrease from the last price of 46.59.

Analyst Recommendations

The current consensus among 30 polled investment analysts is to Hold stock in GlaxoSmithKline. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.54
Sales
$8.4B
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -36.79%
 
 
 
 
 
 
Growthannually -9.36%
 
 
 
 
 
 

Sales

Growthquarterly -12.83%
 
 
 
 
 
 
Growthannually 2.10%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account